Insider Selling: David Ashley Lee Sells 10,000 Shares of CryoLife Stock (CRY)
CryoLife (NYSE:CRY) CFO David Ashley Lee unloaded 10,000 shares of CryoLife stock on the open market in a transaction dated Thursday, August 14th. The shares were sold at an average price of $10.51, for a total transaction of $105,100.00. Following the sale, the chief financial officer now directly owns 228,609 shares in the company, valued at approximately $2,402,681. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
CryoLife (NYSE:CRY) traded up 0.77% during mid-day trading on Friday, hitting $10.43. 114,362 shares of the company’s stock traded hands. CryoLife has a one year low of $6.01 and a one year high of $12.14. The stock’s 50-day moving average is $9.52 and its 200-day moving average is $9.50. The company has a market cap of $291.3 million and a P/E ratio of 19.31.
CryoLife (NYSE:CRY) last released its earnings data on Thursday, July 24th. The company reported $0.08 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.05 by $0.03. The company had revenue of $34.69 million for the quarter, compared to the consensus estimate of $35.72 million. During the same quarter in the prior year, the company posted $0.08 earnings per share. The company’s quarterly revenue was up 3.6% on a year-over-year basis. Analysts expect that CryoLife will post $0.20 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, September 19th. Investors of record on Friday, September 12th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date of this dividend is Wednesday, September 10th.
CryoLife, Inc (NYSE:CRY) is a biological medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.